Gene Salkind - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Gene Salkind has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $674K.
Profile
Gene Salkind is a beneficial owner of more than 10% of UPEXI, INC. (UPXI), as disclosed in SEC ownership filings. SEC records also connect Salkind to Coeptis Therapeutics Holdings, Inc. (ZSQR) and Mobiquity Technologies, Inc. (MOBQ). Salkind has reported 8 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | Insider |
|---|---|
| Notability | 36/100 |
Board memberships
- UPEXI, INC.
- Coeptis Therapeutics Holdings, Inc.
- Mobiquity Technologies, Inc.
Reported roles
- Director
- Director
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| Total purchases tracked | 3 |
|---|
Trading Pattern
InsiderAlpha's records for Gene Salkind go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. The typical open-market purchase is $224K (3 buys totaling $674K). The largest single buy on record is $281K of UPXI in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Gene Salkind has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at UPEXI, INC. (UPXI) - 3 filings, 2025 to 2026
- Director at Coeptis Therapeutics Holdings, Inc. (ZSQR) - 1 filing, 2026
- Director, 10% Owner at Mobiquity Technologies, Inc. (MOBQ) - 3 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-13 | ZSQR | Coeptis Therapeutics Holdings, Inc. | A - Grant or award | 3.2K | $0.00 | |
| 2026-02-13 | ZSQR | Coeptis Therapeutics Holdings, Inc. | M - Option exercise | 5.7K | $10.56 | $60K |
| 2025-11-21 | UPXI | UPEXI, INC. | P - Open-market purchase | 50.0K | $2.55 | $127K |
| 2025-11-18 | UPXI | UPEXI, INC. | P - Open-market purchase | 100.0K | $2.81 | $281K |
| 2025-11-18 | UPXI | UPEXI, INC. | P - Open-market purchase | 100.0K | $2.65 | $265K |
| 2025-09-15 | MOBQ | Mobiquity Technologies, Inc. | A - Grant or award | 25.0K | $1.00 | $25K |
Companies - Last 90 Days
- UPEXI, INC. (UPXI) - 1 filing, last 2026-07-20
Most Active Insiders Right Now
Gene Salkind has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- General Atlantic (LFT), L.P.
- GENERAL ATLANTIC GENPAR (BERMUDA), L.P.
- GENERAL ATLANTIC GENPAR, L.P.
- GENERAL ATLANTIC, L.P.
- A/S Genmab
- Asher Genoot
- Gregory George
- Simeon George
Frequently Asked Questions
Who is Gene Salkind?
Gene Salkind is a beneficial owner of more than 10% of UPEXI, INC. (UPXI), as disclosed in SEC ownership filings. SEC records also connect Salkind to Coeptis Therapeutics Holdings, Inc. (ZSQR) and Mobiquity Technologies, Inc. (MOBQ). Salkind has reported 8 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Gene Salkind submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Gene Salkind been buying or selling stock?
Recorded transactions: 3 open-market purchases ($674K) and 0 open-market sales across all tracked filings.
How accurate is Gene Salkind's historical track record?
Across 3 tracked purchases, Gene Salkind averaged no 30-day data yet with a win rate pending. InsiderAlpha rates the track record at –/5 stars.
Where can I see all of Gene Salkind's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Gene Salkind profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.